Genetic inflammatory factors predict restenosis after percutaneous coronary interventions

Area of Science:

• Cardiovascular Genetics
• Inflammatory Pathways
• Interventional Cardiology

Background:

• Restenosis, a complication of percutaneous coronary intervention (PCI), lacks effective clinical risk stratification tools.
• Genetic factors and inflammation are recognized as significant contributors to the restenotic process.
• Previous association studies suggest genetic predispositions to restenosis, but require validation in larger prospective cohorts.

Purpose of the Study:

• To identify specific gene polymorphisms and haplotypes within inflammatory pathways that may predispose individuals to restenosis after PCI.
• To investigate the role of genetic variations in the inflammatory response contributing to restenosis.
• To enhance risk stratification for restenosis by exploring genetic markers.

Main Methods:

• The GENetic DEterminants of Restenosis (GENDER) project enrolled 3104 patients undergoing successful PCI.
• Analysis of 48 polymorphisms across 34 genes involved in inflammatory pathways.
• Statistical analysis including multiple testing corrections and permutation analysis to assess significance.

Main Results:

• The 16Gly variant of the beta2-adrenergic receptor was linked to an increased risk of target vessel revascularization (TVR).
• Rare alleles in CD14 (-260T/T), colony-stimulating factor 2 (117Thr/Thr), and eotaxin (-1328A/A) genes were associated with a decreased risk of TVR.
• The probability of observing these four significant markers by chance, after corrections, was 12%.

Conclusions:

• Polymorphisms in four genes related to inflammatory responses demonstrated an association with TVR post-PCI.
• These findings may advance the understanding of the molecular mechanisms underlying the restenotic process.
• The results are considered exploratory and necessitate replication in independent studies to confirm their clinical relevance.